BioTelemetry, Inc. Reports First Quarter 2017 Financial Results
Company Reports Record Quarterly Revenue and Patient Volume
Company Reports Record Quarterly Revenue and Patient Volume
BioTelemetry, Inc. (NASDAQ:BEAT) will release its first quarter 2017 earnings on Wednesday, May 3, 2017 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, May 3, 2017. The broadcast will be available through the investor information section of the BioTelemetry website at www.gobio.com.
BioTelemetry, Inc. (NASDAQ:BEAT) and LifeWatch AG (SIX:LIFE) announced today that BioTelemetry published the prospectus for the public tender offer for all publicly held registered shares of LifeWatch AG.
BioTelemetry, Inc. (NASDAQ:BEAT) will hold an investor call tomorrow, April 10, 2017 at 9:00am EDT to discuss the recently announced transaction agreement for BioTelemetry to launch a tender offer to acquire LifeWatch AG. The broadcast will be available through the investor information section of the BioTelemetry website: www.gobio.com. If you are unable to participate during the live webcast, an archive will be available on our website for two weeks.
BioTelemetry, Inc. (NASDAQ:BEAT) and LifeWatch AG (SIX:LIFE) announced today that the companies have entered into a definitive transaction agreement under which BioTelemetry will launch a tender offer in Switzerland to acquire all of the outstanding shares of LifeWatch AG.
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the fourth quarter and full year ended December 31, 2016.
BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2016 earnings on Wednesday, February 22, 2017 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, February 22, 2017. The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com.
Sprint (NYSE:S) announced today that a 2017 IoT Evolution Business Impact Award will be presented to Sprint and its client, BioTelemetry, Inc., by TMC and Crossfire Media at the IoT Evolution Conference & Expo on February 9, 2017. Sprint and BioTelemetry will present the winning case at the Expo.
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, is pleased to announce the acquisition of Telcare Medical Supply, Inc. and associated assets (“Telcare”), increasing the Company’s presence in the large and rapidly growing digital population health management market.
© 2023 BioTelemetry, a Philips Company. All rights reserved